Overall Score

Growth

No revenue or margin growth evidence is available in the current metrics set, and profitability ratios remain at or near zero.

Operating performance is still negative, with operating return on assets at -0.24% and return on invested capital at -0.24%.

Profitability

Margins are effectively zero across gross, operating, EBITDA, pretax, and net profit lines, indicating no demonstrated earnings power.

Return on equity is only 3.5% and return on assets is 3.4%, which is too low to support a strong long-term compounding case.

Financial Health

Liquidity is tight with a current ratio of 0.77, though cash ratio is a healthier 0.62.

Leverage is minimal, with debt-to-equity at 0.08% and debt-to-assets at 0.08%, but negative working capital of -132,101 remains a concern.

Valuation

The stock screens as optically cheap on book value, with price-to-book at 1.00 and price-to-fair-value at 1.00.

However, cash flow-based valuation is extremely weak, with free cash flow yield at -0.11% and price-to-free-cash-flow at -872.25, which limits the quality of the valuation case.